UniProt ID | GLMN_HUMAN | |
---|---|---|
UniProt AC | Q92990 | |
Protein Name | Glomulin | |
Gene Name | GLMN | |
Organism | Homo sapiens (Human). | |
Sequence Length | 594 | |
Subcellular Localization | ||
Protein Description | Essential for normal development of the vasculature. May represent a naturally occurring ligand of the immunophilins FKBP59 and FKBP12. May function as an membrane anchoring protein. Isoform 1 may stimulate the p70S6K pathway. Isoform 2 may inhibit cell proliferation and increase IL2 production.. | |
Protein Sequence | MAVEELQSIIKRCQILEEQDFKEEDFGLFQLAGQRCIEEGHTDQLLEIIQNEKNKVIIKNMGWNLVGPVVRCLLCKDKEDSKRKVYFLIFDLLVKLCNPKELLLGLLELIEEPSGKQISQSILLLLQPLQTVIQKLHNKAYSIGLALSTLWNQLSLLPVPYSKEQIQMDDYGLCQCCKALIEFTKPFVEEVIDNKENSLENEKLKDELLKFCFKSLKCPLLTAQFFEQSEEGGNDPFRYFASEIIGFLSAIGHPFPKMIFNHGRKKRTWNYLEFEEEENKQLADSMASLAYLVFVQGIHIDQLPMVLSPLYLLQFNMGHIEVFLQRTEESVISKGLELLENSLLRIEDNSLLYQYLEIKSFLTVPQGLVKVMTLCPIETLRKKSLAMLQLYINKLDSQGKYTLFRCLLNTSNHSGVEAFIIQNIKNQIDMSLKRTRNNKWFTGPQLISLLDLVLFLPEGAETDLLQNSDRIMASLNLLRYLVIKDNENDNQTGLWTELGNIENNFLKPLHIGLNMSKAHYEAEIKNSQEAQKSKDLCSITVSGEEIPNMPPEMQLKVLHSALFTFDLIESVLARVEELIEIKTKSTSEENIGIK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAVEELQSI ------CHHHHHHHH | 19.89 | 22223895 | |
8 | Phosphorylation | MAVEELQSIIKRCQI CHHHHHHHHHHHHHH | 38.62 | 24719451 | |
11 | Ubiquitination | EELQSIIKRCQILEE HHHHHHHHHHHHHCC | 45.51 | - | |
53 | Ubiquitination | LEIIQNEKNKVIIKN HHHHHCCCCCEEEEC | 70.40 | - | |
55 | Ubiquitination | IIQNEKNKVIIKNMG HHHCCCCCEEEECCC | 45.97 | - | |
59 | Ubiquitination | EKNKVIIKNMGWNLV CCCCEEEECCCCCCH | 29.74 | - | |
86 | Phosphorylation | EDSKRKVYFLIFDLL HHHCCHHHHHHHHHH | 8.83 | - | |
185 (in isoform 2) | Ubiquitination | - | 41.60 | 21906983 | |
185 (in isoform 1) | Ubiquitination | - | 41.60 | 21906983 | |
185 | Ubiquitination | KALIEFTKPFVEEVI HHHHHHHHHHHHHHH | 41.60 | 21906983 | |
195 | Ubiquitination | VEEVIDNKENSLENE HHHHHHCCCCCCCCH | 55.30 | - | |
198 | Phosphorylation | VIDNKENSLENEKLK HHHCCCCCCCCHHHH | 37.85 | - | |
203 | Ubiquitination | ENSLENEKLKDELLK CCCCCCHHHHHHHHH | 72.86 | - | |
214 | Ubiquitination | ELLKFCFKSLKCPLL HHHHHHHHHCCCCHH | 56.94 | - | |
217 | Ubiquitination | KFCFKSLKCPLLTAQ HHHHHHCCCCHHHHH | 40.68 | - | |
271 | Phosphorylation | RKKRTWNYLEFEEEE CCCCCEECCCCCHHH | 10.12 | 27642862 | |
330 | Phosphorylation | FLQRTEESVISKGLE HHHHHHHHHHHHHHH | 20.65 | 22468782 | |
333 | Phosphorylation | RTEESVISKGLELLE HHHHHHHHHHHHHHH | 20.65 | 22468782 | |
353 | Phosphorylation | IEDNSLLYQYLEIKS EECCCHHHHHHHHHH | 10.62 | 25147952 | |
383 | Acetylation | PIETLRKKSLAMLQL CHHHHHHHHHHHHHH | 44.24 | 7711421 | |
391 | Phosphorylation | SLAMLQLYINKLDSQ HHHHHHHHHHHHCCC | 6.89 | - | |
431 | Phosphorylation | IKNQIDMSLKRTRNN HHHHHHHHCCCCCCC | 27.30 | 24719451 | |
433 | Ubiquitination | NQIDMSLKRTRNNKW HHHHHHCCCCCCCCC | 44.40 | 21906983 | |
433 (in isoform 1) | Ubiquitination | - | 44.40 | 21906983 | |
435 | Phosphorylation | IDMSLKRTRNNKWFT HHHHCCCCCCCCCCC | 35.84 | - | |
525 | Ubiquitination | AHYEAEIKNSQEAQK HHHHHHHCCCHHHHH | 41.89 | 21906983 | |
525 (in isoform 1) | Ubiquitination | - | 41.89 | 21906983 | |
584 (in isoform 1) | Ubiquitination | - | 46.89 | 21906983 | |
584 | Ubiquitination | ELIEIKTKSTSEENI HHHHCCCCCCCCCCC | 46.89 | 2190698 | |
585 | Phosphorylation | LIEIKTKSTSEENIG HHHCCCCCCCCCCCC | 42.26 | 30622161 | |
586 | Phosphorylation | IEIKTKSTSEENIGI HHCCCCCCCCCCCCC | 41.53 | 30622161 | |
587 | Phosphorylation | EIKTKSTSEENIGIK HCCCCCCCCCCCCCC | 50.43 | 25159151 | |
594 | Acetylation | SEENIGIK------- CCCCCCCC------- | 49.42 | 164315 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GLMN_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GLMN_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GLMN_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
138000 | Glomuvenous malformations (GVMs) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. |